#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Dementia Alzheimer's type Colorectal cancer Ovarian cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Congenital cystic kidney disease Retinoblastoma Infantile spasms Acute lymphocytic leukaemia recurrent Langerhans' cell histiocytosis Ventricular fibrillation Depression Acute myeloid leukaemia Cystic fibrosis respiratory infection suppression Cutaneous T-cell lymphoma stage II Fabry's disease Congenital absence of bile ducts Congenital disorder of glycosylation B-cell lymphoma Arginase deficiency More trials…

    Learn about Rare Diseases

    Krabbe’s disease – Trials in Disease Skin angiosarcoma – Diagnostics Carcinoid syndrome – Diagnostics Burkitt’s lymphoma Idiopathic pulmonary fibrosis – Trials in Disease Activated PI3 kinase delta syndrome Haemophilia A without inhibitors Primary mediastinal large B-cell lymphoma – Trials in Disease Hereditary hypophosphataemic rickets – Life with Disease Prader-Willi syndrome – Basic Information More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Sodium Glycocholate Mometasone Ceralasertib 19Cp02 Alemtuzumab Dactylis Glomerata Dl-Alpha-Tocopherol Gallium Citrate Ga-68 Darbepoetin Alfa Rtx001 Fosaprepitant Asp1570 Fluoxetine Tng462 GSK5784283 Izorlisib Mesilate Pasireotide Diaspartate STREPTOCOCCUS PYOGENES Lumasiran Glutathione More therapies…

    Learn about Your Condition

    Craniopharyngioma Decreased appetite Thalassaemia Mitral valve disease Oropharyngeal cancer Weaning failure Cardiovascular disorder Marginal zone lymphoma Bone sarcoma Pancreatic fistula Acute on chronic liver failure Lung adenocarcinoma stage IV Hairy cell leukaemia recurrent Myopia Diminished ovarian reserve More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

ABM

  • Study on Ketamine and Midazolam for Treating Obsessive-Compulsive Disorder in Adults

    Recruiting

    3 1 1
    Investigated Diseases:
    • Obsessive-compulsive disorder
    Investigated Drugs:
    • Ketamine
    • Midazolam Hydrochloride
    Austria

  • Study on the Effects of Fludrocortisone in Treating Neurogenic Orthostatic Hypotension in Patients

    Recruiting

    3 1 1
    Investigated Diseases:
    • Orthostatic hypotension
    Investigated Drugs:
    • Fludrocortisone Acetate
    France

  • Study on the Effects of Pentoxifylline, Retinol Acetate, and DL-Alpha Tocopherol Acetate for Patients with Medication-Related Osteonecrosis of the Jaw

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Osteonecrosis of jaw
    Investigated Drugs:
    • Dl-Alpha Tocopherol Acetate
    • Pentoxifylline
    • Retinol Acetate
    France

  • Study on Early Rituximab Treatment for Children with Nephrotic Syndrome

    Recruiting

    3 1 1
    Investigated Diseases:
    • Nephrotic syndrome
    Investigated Drugs:
    • Rituximab
    Poland

  • Study on the Effects of Wharton’s Jelly Mesenchymal Stem Cells, Pirfenidone, and Nintedanib for Patients with Fibrotic Interstitial Lung Disease

    Recruiting

    1 1 1
    Investigated Diseases:
    • Interstitial lung disease
    Investigated Drugs:
    • Allogeneic Wharton’s Jelly-Derived Mesenchymal Stem Cells
    • Pirfenidone
    • Nintedanib
    Poland

  • Study on Clebopride for Treating Rumination Syndrome in Patients Suspected of Having the Condition

    Recruiting

    3 1 1
    Investigated Diseases:
    • Merycism
    Investigated Drugs:
    • Clebopride Hydrogen Maleate
    Belgium
Previous Page
1 … 634 635 636 637 638 … 1,655
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!